首页> 外文期刊>Acta biomaterialia >Injectable and biodegradable thermosensitive hydrogels loaded with PHBHHx nanoparticles for the sustained and controlled release of insulin
【24h】

Injectable and biodegradable thermosensitive hydrogels loaded with PHBHHx nanoparticles for the sustained and controlled release of insulin

机译:装有PHBHHx纳米粒子的可注射和可生物降解的热敏水凝胶,用于胰岛素的持续和控制释放

获取原文
获取原文并翻译 | 示例

摘要

Biodegradable PHBHHx (poly(3-hydroxybutyrate-co-3-hydroxyhexanoate)) nanoparticles containing insulin phospholipid complex were loaded in chitosan-based thermosensitive hydrogels for long-term sustained and controlled delivery of insulin. The injectable hydrogels, prepared by adding ??-glycerophosphate disodium salt (GP) solution to chitosan (CS) solution under stirring, showed a rapid solution-to-gel transition at 37??C, a porous structure and a comparative degradation and swelling rate in vitro. In the in vitro release studies, only 19.11% of total insulin was released from the nanoparticle-loaded hydrogel (NP-CS/GP) within 31 days. However, 96.41% of total insulin was released from the free insulin-loaded hydrogel (INS-CS/GP) within 16 days. Most importantly, the hypoglycemic effect of NP-CS/GP following subcutaneous injection in diabetic rats lasted for >5 days, much longer than the effect caused by INS-CS/GP or other long-Acting insulin formulations. The pharmacological availability of NP-CS/GP relative to INS-CS/GP was 379.85%, indicating that the bioavailability of insulin was significantly enhanced by NP-CS/GP gels. Therefore, biodegradable and thermosensitive NP-CS/GP gels have great potential for use in novel ultralong-Acting insulin injections. In addition, the NP-loaded hydrogel system also paves the way for long-term delivery of other proteins and peptides. ? 2012 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
机译:将包含胰岛素磷脂复合物的可生物降解的PHBHHx(聚(3-羟基丁酸酯-co-3-羟基己酸酯))纳米颗粒装入基于壳聚糖的热敏水凝胶中,以长期持续且受控地输送胰岛素。在搅拌下将β-甘油磷酸二钠盐(GP)溶液加入壳聚糖(CS)溶液中制备的可注射水凝胶在37℃时显示出快速的溶液-凝胶转变,多孔结构以及相对的降解和溶胀性。体外速率。在体外释放研究中,仅31.11%的总胰岛素从负载纳米颗粒的水凝胶(NP-CS / GP)释放了31天。但是,总胰岛素的96.41%在16天之内从装有胰岛素的游离水凝胶(INS-CS / GP)中释放出来。最重要的是,在糖尿病大鼠中皮下注射后,NP-CS / GP的降血糖作用持续超过5天,比INS-CS / GP或其他长效胰岛素制剂引起的作用长得多。相对于INS-CS / GP,NP-CS / GP的药理学利用率为379.85%,表明NP-CS / GP凝胶显着提高了胰岛素的生物利用率。因此,可生物降解和热敏性的NP-CS / GP凝胶在新型超长效胰岛素注射剂中具有巨大的潜力。另外,装载NP的水凝胶系统也为长期输送其他蛋白质和肽铺平了道路。 ? 2012年Acta Materialia Inc.由Elsevier Ltd.发行。保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号